DEEPAI.BO · BSE
Deep Health AI India Limited
₹1.79
+2.29% (+₹0.04)
Prev. close
₹1.75
Volume
1
As of
BSE · may be slightly delayed · 11:28 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About Deep Health AI India Limited
Deep Health AI India Limited engages in the manufacturing and sales of gold and diamond studded jewelry products in India. The company operates through two segments, Diamond Jewellery and Pharmaceuticals. It provides pendants, nose pins, rings, bangles, earrings, pendant sets, necklace sets, bracelets, and other jewelry products. The company also deals in loose diamonds, solitaires, and gold frames, as well as offers rough and polished diamonds. In addition, it engages in the marketing of pharmaceutical goods, as well as offers consultancy related to marketing of pharmaceutical products. Deep Health AI India Limited was formerly known as Deep Diamond India Limited and changed its name to Deep Health AI India Limited in February 2026. The company was incorporated in 1994 and is based in Udaipur, India.
Details
Sector
Healthcare
Industry
Health Information Services
CEO
Mr. Narayan Singh Rathore
Headquarters
Udaipur
Employees
8
Website
deephealthaiindia.comExchange
View on BSE ↗Key stats
Market cap
₹25.23 Cr
P/E ratio (TTM)
15.7
Dividend yield
11.43%
EPS (TTM)
₹-0.05
Beta (1Y · daily vs NIFTY 50)
0.96
Beta (5Y · monthly vs NIFTY 50)
2.77
Shares float
10.02 Cr
EPS · quarter ended Jun 2026
₹-0.15
Financial Performance
01 · Financials
Revenue for Mar 2021–Mar 2022 is as filed with BSE (standalone), and the first plotted growth figure is computed against Mar 2020 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY21 growth needs FY20 filings, which the data source doesn't provide. EBITDA is omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| ₹51.10 L | ₹1.39 Cr | ₹7.67 Cr | ₹2.56 Cr | ₹1.26 Cr | ₹4.25 Cr | |
| EBITDA | — | — | ₹1.85 Cr | ₹78.48 L | ₹1.19 Cr | ₹1.63 Cr |
| ₹-4.70 L | ₹19.70 L | ₹1.26 Cr | ₹41.68 L | ₹87.65 L | ₹1.13 Cr | |
| Diluted EPS | ₹-0.15 | ₹0.62 | ₹3.1 | ₹0.13 | ₹0.17 | ₹0.11 |
Depreciation & amortisation, EBITDA, Pretax income, Tax provision, Interest expense have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹19.88 Cr | ₹23.06 Cr | ₹23.94 Cr | ₹52.08 Cr | |
| — | — | ₹3.86 Cr | ₹1.66 Cr | ₹60.85 L | ₹37.28 L | |
| Stockholders' equity | — | — | ₹14.73 Cr | ₹20.42 Cr | ₹22.34 Cr | ₹51.37 Cr |
Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| — | — | ₹2.02 L | ₹-5.43 Cr | ₹1.34 Cr | ₹-3.66 Cr | |
| Investing cash flow | — | — | ₹-4.03 L | ₹-2.23 Cr | ₹-23.26 L | ₹-29.20 Cr |
| — | — | ₹5.79 L | ₹5.01 Cr | ₹-1.15 Cr | ₹37.87 Cr | |
| Capital expenditure | — | — | ₹-4.48 L | — | ₹-9,800 | ₹-36,000 |
| End cash position | — | — | ₹1.02 Cr | ₹3.37 Cr | ₹3.32 Cr | ₹8.34 Cr |
Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.41 L Cr | ₹1,868.9 | 36.5 | 5.27 | 13.7% | 0.06 | +11.9% | +12.9% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.29 L Cr | ₹8,912 | 61.7 | 13.57 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.25 L Cr | ₹683.85 | 188.8 | 14.29 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.13 L Cr | ₹1,386.1 | 33.4 | 3.27 | 11.3% | 0.02 | +2.1% | -12.0% |
| Laurus Labs Limited | ₹1.06 L Cr | ₹2,017.5 | 96.2 | 19.92 | 16.8% | 0.48 | +22.0% | +116.4% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Aurobindo Pharma Limited | ₹99,770.53 Cr | ₹1,713.4 | 27.1 | 2.63 | 9.2% | 0.21 | +6.4% | +53.1% |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| Deep Health AI India Limited | ₹25.37 Cr | ₹1.75 | 15.7 | 0.49 | 2.2% | 0.01 | +237.5% | — |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Show all 24
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.